BLB OFFERS THE POSSIBILITY TO TEST YOUR COMPOUNDS IN HUMAN PCLS
PCLS are generated rapidly upon donation allowing reliable assessment of compounds efficacy. Upon incubation, tissues are processed for a variety of endpoints including gene and protein expression, immunohistochemistry and immunofluorescence. Media is also collected for the assessment of secreted factors. Let us analyze the effects of your compounds in healthy or diseased human PCLS.
The complete pre-clinical Solution
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers